Walleye Capital LLC Guardant Health, Inc. Put Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.3 - $36.29 $642,240 - $1.05 Million
-28,800 Reduced 58.78%
20,200 $463,000
Q2 2024

Aug 14, 2024
BUY
$16.07 - $31.84 $708,687 - $1.4 Million
44,100 Added 900.0%
49,000 $1.42 Million
Q1 2024

May 15, 2024
SELL
$17.13 - $26.91 $53,103 - $83,421
-3,100 Reduced 38.75%
4,900 $101,000
Q4 2023

Feb 14, 2024
SELL
$21.58 - $29.5 $82,004 - $112,100
-3,800 Reduced 32.2%
8,000 $216,000
Q3 2023

Nov 14, 2023
SELL
$25.8 - $39.97 $18,060 - $27,979
-700 Reduced 5.6%
11,800 $349,000
Q2 2023

Aug 14, 2023
BUY
$20.94 - $38.01 $90,042 - $163,443
4,300 Added 52.44%
12,500 $447,000
Q1 2023

May 15, 2023
SELL
$22.92 - $33.76 $213,156 - $313,968
-9,300 Reduced 53.14%
8,200 $192,000
Q4 2022

Feb 14, 2023
BUY
$25.44 - $59.78 $409,584 - $962,458
16,100 Added 1150.0%
17,500 $476,000
Q3 2022

Nov 14, 2022
BUY
$43.66 - $61.0 $61,123 - $85,400
1,400 New
1,400 $75,000
Q1 2020

May 15, 2020
SELL
$59.04 - $88.81 $23,616 - $35,524
-400 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$59.49 - $82.78 $5,949 - $8,278
-100 Reduced 20.0%
400 $31,000
Q3 2019

Nov 14, 2019
SELL
$62.59 - $110.3 $31,295 - $55,150
-500 Reduced 50.0%
500 $32,000
Q2 2019

Aug 14, 2019
BUY
$63.94 - $91.11 $63,940 - $91,110
1,000 New
1,000 $86,000

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email